{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T08:41:12Z","timestamp":1790844072835,"version":"4.1.0"},"reference-count":43,"publisher":"Manuscript Technomedia LLP","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Young Pharmacists"],"published-print":{"date-parts":[[2010,1]]},"DOI":"10.4103\/0975-1483.62219","type":"journal-article","created":{"date-parts":[[2010,4,22]],"date-time":"2010-04-22T01:27:59Z","timestamp":1271899679000},"page":"74-78","source":"Crossref","is-referenced-by-count":29,"title":["Anti-allergic Activity of Stem Bark of Myrica esculenta Buch.-Ham. (Myricaceae)"],"prefix":"10.5530","volume":"2","author":[{"given":"K.G","family":"Patel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.J.","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.G.","family":"Gajera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.A.","family":"Bhatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.V.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.R.","family":"Gandhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3478","reference":[{"key":"10.4103\/0975-1483.62219_bb0005","first-page":"225","article-title":"Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, Nov 1986","volume":"136","author":"Standards for the diagnosis","year":"1987","journal-title":"Am Rev Respir Dis"},{"key":"10.4103\/0975-1483.62219_bb0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/oxfordjournals.bmb.a072526","article-title":"Asthma. Definition and clinical spectrum.","volume":"48","author":"Pride","year":"1992","journal-title":"Br Med Bull"},{"key":"10.4103\/0975-1483.62219_bb0015","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1093\/oxfordjournals.bmb.a072537","article-title":"Pathology of asthma","volume":"48","author":"Jeffery","year":"1992","journal-title":"Br Med Bull"},{"key":"10.4103\/0975-1483.62219_bb0020","doi-asserted-by":"crossref","first-page":"S41","DOI":"10.1164\/ajrccm.159.supplement_2.mfa-1","article-title":"The many faces of airway inflammation-Asthma and Chronic obstructive pulmonary disease","volume":"159","author":"O'byrne","year":"1999","journal-title":"Am J Respir Crit Care Med."},{"key":"10.4103\/0975-1483.62219_bb0025","doi-asserted-by":"crossref","first-page":"193","DOI":"10.2165\/00003495-200059020-00004","article-title":"Phosphodiesterase 4 inhibitors and the treatment of asthma-where are we now and where do we go from here","volume":"59","author":"Giembycz","year":"2000","journal-title":"Drugs"},{"key":"10.4103\/0975-1483.62219_bb0030","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1164\/ajrccm\/148.4_Pt_2.S1","article-title":"Efficacy and safety of inhaled corticosteroids in asthma. Report of a workshop held in Eze, France, October 1992","volume":"148","author":"Barnes","year":"1993","journal-title":"Am Rev Respir Dis"},{"key":"10.4103\/0975-1483.62219_bb0035","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1046\/j.1365-2273.2003.00706.x","article-title":"Allergic rhinitis: Past, present and the future","volume":"28","author":"Salib","year":"2003","journal-title":"Clin Otolaryngol Allied Sci"},{"key":"10.4103\/0975-1483.62219_bb0040","first-page":"1699","volume":"Vol. III","author":"Kirtikar","year":"1999"},{"key":"10.4103\/0975-1483.62219_bb0045","first-page":"871","volume":"Vol. I","author":"Nadkarni's","year":"2002"},{"key":"10.4103\/0975-1483.62219_bb0050","first-page":"312","article-title":"Evaluation of the effect of Myrica sapida on bronchoconstriction and bronchial hyperreactivity","volume":"63","author":"Patel","year":"2008","journal-title":"Pharmazie"},{"key":"10.4103\/0975-1483.62219_bb0055","first-page":"191","article-title":"Evaluation of bronchodilator and antianphylactic activity of Myrica sapida","volume":"12","author":"Patel","year":"2008","journal-title":"Iran Biomed J"},{"key":"10.4103\/0975-1483.62219_bb0060","first-page":"10","year":"1999"},{"key":"10.4103\/0975-1483.62219_bb0065","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1164\/ajrccm\/147.6_Pt_2.S20","article-title":"Mechanism of airway inflammation in asthma","volume":"147","author":"Busse","year":"1993","journal-title":"Am Rev Respir Dis"},{"key":"10.4103\/0975-1483.62219_bb0070","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/0167-5699(92)90026-4","article-title":"T-cell and eosinophils in the pathogenesis of asthma","volume":"13","author":"Corrigan","year":"1992","journal-title":"Immunol Today"},{"key":"10.4103\/0975-1483.62219_bb0075","doi-asserted-by":"crossref","first-page":"243","DOI":"10.3181\/00379727-207-43813A","article-title":"T-lymphocyte dysregulation in asthma","volume":"207","author":"Kline","year":"1994","journal-title":"Proc Soc Exp Biol Med"},{"key":"10.4103\/0975-1483.62219_bb0080","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/0167-5699(94)90004-3","article-title":"Immunological\/ Physiological relationships in asthma: Potential regulation by lung macrophages","volume":"15","author":"Poulter","year":"1994","journal-title":"Immunol Today"},{"key":"10.4103\/0975-1483.62219_bb0085","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/j.1365-2249.1991.tb05607.x","article-title":"Characterization of immune inducer and suppressor macrophage from normal human lung","volume":"83","author":"Spiteri","year":"1991","journal-title":"Clin Exp Immunol"},{"key":"10.4103\/0975-1483.62219_bb0090","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/0167-5699(95)80128-6","article-title":"Nitric oxide and asthmatic inflammation","volume":"16","author":"Barnes","year":"1991","journal-title":"Immunol Today"},{"key":"10.4103\/0975-1483.62219_bb0095","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/BF02723192","article-title":"Tumour necrosis factors in childhood Asthma","volume":"68","author":"Najam","year":"2001","journal-title":"Indian J Pediatr"},{"key":"10.4103\/0975-1483.62219_bb0100","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/BF02845519","article-title":"Immunoglobulin isotypes in childhood asthma","volume":"66","author":"Najam","year":"1999","journal-title":"Indian J Pediatr"},{"key":"10.4103\/0975-1483.62219_bb0105","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/j.jaci.2004.07.039","article-title":"Cysteinyl leukotriene receptor antagonist regulates vascular permeability by reducing vascular endothelial growth factor expression","volume":"114","author":"Lee","year":"2004","journal-title":"J Allergy Clin Immunol"},{"key":"10.4103\/0975-1483.62219_bb0110","doi-asserted-by":"crossref","first-page":"3595","DOI":"10.4049\/jimmunol.168.7.3595","article-title":"Contribution of vascular endothelial growth factor to airway hyperresponsiveness and inflammation in a murine model of toluene diisocyanate induced asthma","volume":"168","author":"Lee","year":"2002","journal-title":"J Immunol"},{"key":"10.4103\/0975-1483.62219_bb0115","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1038\/74725","article-title":"Angiopoietin-1 protects the adult vasculature against plasma leakage","volume":"6","author":"Thurston","year":"2000","journal-title":"Nat Med"},{"key":"10.4103\/0975-1483.62219_bb0120","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/j.1476-5381.1964.tb02030.x","article-title":"The use of changes in capillary permeability in mice to distinguish between narcotic and nonnarcotic analgesics","volume":"22","author":"Whittle","year":"1964","journal-title":"Br J Pharmacol Chemother"},{"key":"10.4103\/0975-1483.62219_bb0125","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0378-8741(01)00387-7","article-title":"Berberis crataegina DC. root exhibits potent anti-inflammatory, analgesic and febrifuge effects in mice and rats","volume":"79","author":"Ye\u015filada","year":"2002","journal-title":"J Ethnopharmacol"},{"key":"10.4103\/0975-1483.62219_bb0130","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1002\/jlb.67.2.189","article-title":"Role of endothelins on lymphocyte accumulation in allergic pleurisy","volume":"67","author":"Sampaio","year":"2000","journal-title":"J Leukoc Biol"},{"key":"10.4103\/0975-1483.62219_bb0135","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/j.1476-5381.1990.tb14671.x","article-title":"Differential inhibition by two hetrazepine PAF antagonists of acute inflammation in the mouse","volume":"99","author":"Henriques","year":"1990","journal-title":"Br J Pharmacol"},{"key":"10.4103\/0975-1483.62219_bb0140","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1038\/74725","article-title":"Angiopoietin-1 protects the adult vasculature against plasma leakage","volume":"6","author":"Thurston","year":"2000","journal-title":"Nat Med"},{"key":"10.4103\/0975-1483.62219_bb0145","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1164\/ajrccm\/143.2.362","article-title":"Respiratory membrane permeability and bronchial hyperreactivity in patients with stable asthma","volume":"143","author":"Van de Graaf","year":"1991","journal-title":"Effects of therapy with inhaled steroids. Am Rev Respir Dis"},{"key":"10.4103\/0975-1483.62219_bb0150","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1164\/ajrccm\/153.6_Pt_2.S9","article-title":"Epithelial cells: Barrier functions and sheddingrestitution mechanisms","volume":"153","author":"Persson","year":"1996","journal-title":"Am J Respir Crit Care Med"},{"key":"10.4103\/0975-1483.62219_bb0155","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1093\/annhyg\/26.2.227","article-title":"Lung mucociliary function in man: Interdependence of bronchial and tracheal mucus transport velocities with lung clearance in bronchial asthma and healthy subjects","volume":"26","author":"Foster","year":"1982","journal-title":"Ann Occup Hyg"},{"key":"10.4103\/0975-1483.62219_bb0160","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/j.jaci.2004.07.039","article-title":"Cysteinyl leukotriene receptor antagonist regulates vascular permeability by reducing vascular endothelial growth factor expression","volume":"114","author":"Lee","year":"2004","journal-title":"J Allergy Clin Immunol"},{"key":"10.4103\/0975-1483.62219_bb0165","doi-asserted-by":"crossref","first-page":"3595","DOI":"10.4049\/jimmunol.168.7.3595","article-title":"Contribution of vascular endothelial growth factor to airway hyperresponsiveness and inflammation in a murine model of toluene diisocyanate induced asthma","volume":"168","author":"Lee","year":"2002","journal-title":"J Immunol"},{"key":"10.4103\/0975-1483.62219_bb0170","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/BF03256635","article-title":"Clinical usefulness of inflammatory markers in asthma","volume":"2","author":"Wark","year":"2003","journal-title":"Am J Respir Med"},{"key":"10.4103\/0975-1483.62219_bb0175","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/j.jaci.2004.02.016","article-title":"Advances in mechanisms of allergy","volume":"113","author":"Bochner","year":"2004","journal-title":"J Allergy Clin Immunol"},{"key":"10.4103\/0975-1483.62219_bb0180","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/0091-6749(93)90175-F","article-title":"Activation of CD41 T cells, increased TH2-type cytokine mRNA expression, and eosinophil recruitment in bronchoalveolar lavage after allergen inhalation challenge in patients with atopic asthma","volume":"92","author":"Robinson","year":"1993","journal-title":"J Allergy Clin Immunol"},{"key":"10.4103\/0975-1483.62219_bb0185","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1182\/blood.V91.7.2240","article-title":"Eotaxin induces a rapid release of eosinophils and their progenitors from the bone marrow","volume":"91","author":"Palframan","year":"1998","journal-title":"Blood"},{"key":"10.4103\/0975-1483.62219_bb0190","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1084\/jem.179.3.881","article-title":"Eotaxin: A potent eosinophil chemoattractant cytokine detected in a guinea pig model of allergic airways inflammation","volume":"179","author":"Jose","year":"1994","journal-title":"J Exp Med"},{"key":"10.4103\/0975-1483.62219_bb0195","doi-asserted-by":"crossref","first-page":"8960","DOI":"10.1073\/pnas.92.19.8960","article-title":"Murine eotaxin: An eosinophil chemoattractant inducible in endothelial cells and in interleukin 4-induced tumor suppression","volume":"92","author":"Rothenberg","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.4103\/0975-1483.62219_bb0200","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1146\/annurev.immunol.15.1.675","article-title":"Human chemokines: An update. Annu 43. Corrigon CJ. Immunological aspects of asthma: Implications for future","volume":"15","author":"Baggiolini","year":"1997","journal-title":"Rev Immunol"},{"key":"10.4103\/0975-1483.62219_bb0205","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S0091-6749(97)70158-1","article-title":"Cellular adhesion and its antagonism","volume":"100","author":"Bochner","year":"1997","journal-title":"J Allergy Clin Immunol"},{"key":"10.4103\/0975-1483.62219_bb0210","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/S0091-6749(99)70069-2","article-title":"Molecular basis for selective eosinophil trafficking in asthma: A multistep paradigm","volume":"104","author":"Wardlaw","year":"1999","journal-title":"J Allergy Clin Immunol"},{"key":"10.4103\/0975-1483.62219_bb0215","first-page":"31","article-title":"Immunological aspects of asthma: Implications for future treatment","volume":"1","author":"Corrigon","year":"1994","journal-title":"Clin Immunol Ther"}],"container-title":["Journal of Young Pharmacists"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T08:55:50Z","timestamp":1771577750000},"score":1,"resource":{"primary":{"URL":"https:\/\/jyoungpharm.org\/article\/2\/1\/74"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,1]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,1]]}},"alternative-id":["S0975148310210154"],"URL":"https:\/\/doi.org\/10.4103\/0975-1483.62219","relation":{},"ISSN":["0975-1483"],"issn-type":[{"value":"0975-1483","type":"print"}],"subject":[],"published":{"date-parts":[[2010,1]]}}}